Related references
Note: Only part of the references are listed.In vivo pro-angiogenic effects of dracorhodin perchlorate in zebrafish embryos: A novel bioactivity evaluation platform for commercial dragon blood samples
Preethi Krishnaraj et al.
JOURNAL OF FOOD AND DRUG ANALYSIS (2019)
Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline
Richard Eastell et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Challenges in osteoporosis awareness and management: results from a survey of US postmenopausal women
E. Michael Lewiecki et al.
JOURNAL OF DRUG ASSESSMENT (2019)
Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities
Yuhao Liu et al.
THERANOSTICS (2019)
Dracorhodin perchlorate inhibits biofilm formation and virulence factors of Candida albicans
L. F. Yang et al.
JOURNAL DE MYCOLOGIE MEDICALE (2018)
Dracorhodin perchlorate regulates fibroblast proliferation to promote rat's wound healing
Xiaowen Jiang et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2018)
Osteoclasts degrade bone and cartilage knee joint compartments through different resorption processes
Henrik Lofvall et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Dracorhodin Perochlorate attenuates Staphylococcus aureus USA300 virulence by decreasing α-toxin expression
Yumin Liu et al.
WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY (2017)
Key Triggers of Osteoclast-Related Diseases and Available Strategies for Targeted Therapies: A Review
Haidi Bi et al.
FRONTIERS IN MEDICINE (2017)
Biomimetic Synthesis of Complex Flavonoids Isolated from Daemonorops Dragon's Blood
Matthias Schmid et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Selective Regulation of MAPK Signaling Mediates RANKL-dependent Osteoclast Differentiation
Kyunghee Lee et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2016)
The angiogenic effect of dracorhodin perchlorate on human umbilical vein endothelial cells and its potential mechanism of action
Feng Li et al.
MOLECULAR MEDICINE REPORTS (2016)
Dracorhodin perchlorate induces G1/G0 phase arrest and mitochondria-mediated apoptosis in SK-MES-1 human lung squamous carcinoma cells
Guangxin Zhang et al.
ONCOLOGY LETTERS (2015)
Dracorhodin perchlorate induces apoptosis in primary fibroblasts from human skin hypertrophic scars via participation of caspase-3
Peihua Zhang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Dracorhodin Perchlorate Induced Human Breast Cancer MCF-7 Apoptosis through Mitochondrial Pathways
Jing-hua Yu et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2013)
NF-κB signaling and bone resorption
Y. Abu-Amer
OSTEOPOROSIS INTERNATIONAL (2013)
Dracorhodin perchlorate inhibits PI3K/Akt and NF-κB activation, up-regulates the expression of p53, and enhances apoptosis
Azhar Rasul et al.
APOPTOSIS (2012)
An overview of the regulation of bone remodelling at the cellular level
Jasreen Kular et al.
CLINICAL BIOCHEMISTRY (2012)
The osteoclast, bone remodelling and treatment of metabolic bone disease
Brendan F. Boyce et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2012)
Dracorhodin Perchlorate Suppresses Proliferation and Induces Apoptosis in Human Prostate Cancer Cell Line PC-3
Yuanqiao He et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2011)
Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation
Takako Negishi-Koga et al.
IMMUNOLOGICAL REVIEWS (2009)
JNK/c-Jun signaling mediates an anti-apoptotic effect of RANKL in osteoclasts
Fumiyo Ikeda et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Dracorhodin perchlorate induces apoptosis in HL-60 cells
M. -Y. Xia et al.
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH (2006)
Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation
F Ikeda et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Osteoclast diseases
MH Helfrich
MICROSCOPY RESEARCH AND TECHNIQUE (2003)
Osteoclast differentiation and activation
WJ Boyle et al.
NATURE (2003)
Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts
H Takayanagi et al.
DEVELOPMENTAL CELL (2002)
Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF-κB ligand
JK Xu et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
Share Paper
